|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/192 | |
| A61P 21/00 | |||
| A61K 9/00 | |||
| A61K 31/5375 | |||
| C07D 295/096 |
| (11) | Number of the document | 3043789 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14784385.8 |
| Date of filing the European patent application | 2014-09-05 | |
| (97) | Date of publication of the European application | 2016-07-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/054303 |
| Date | 2014-09-05 |
| (87) | Number | WO 2015/035171 |
| Date | 2015-03-12 |
| (30) | Number | Date | Country code |
| 201361875214 P | 2013-09-09 | US | |
| 201361896343 P | 2013-10-28 | US |
| (72) |
VALCARCE LOPEZ, Maria Carmen, US
OHLSTEIN, Eliot, US
|
| (73) |
vTv Therapeutics LLC,
3980 Premier Drive, Suite 310, High Point, NC 27265,
US
|
| (54) | USE OF A PPAR-DELTA AGONISTS FOR TREATING MUSCLE ATROPHY |
| USE OF A PPAR-DELTA AGONISTS FOR TREATING MUSCLE ATROPHY |